MorphoSys AG | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
13,321.90
3,012.60
14,900.80
60,382.80
69,826.50
56,172.10
Depreciation, Depletion & Amortization
4,834.40
4,134.50
3,454.80
3,763.80
4,028.90
3,750.30
Other Funds
23,271.80
29,766.10
66,320.10
2,953.00
4,899.40
27,965.50
Funds from Operations
5,115.40
28,644.20
47,964.50
59,571.90
70,696.90
28,760.10
Changes in Working Capital
94,253.00
14,425.90
25,913.30
14,962.70
32,508.80
4,507.60
Net Operating Cash Flow
89,137.60
14,218.40
22,051.10
44,609.20
38,188.10
33,267.70
Capital Expenditures
5,563.60
20,478.70
8,765.40
2,913.50
13,148.80
Sale of Fixed Assets & Businesses
6.00
5.00
3.10
5.00
0.10
Purchase/Sale of Investments
120,422.10
86,457.20
15,844.90
26,719.40
16,675.10
Net Investing Cash Flow
193,856.70
21,498.60
84,802.70
82,794.40
32,674.80
Issuance/Reduction of Debt, Net
225.00
-
-
-
-
Net Financing Cash Flow
130,626.40
3,919.20
4,062.20
110,404.60
8,173.80
Net Change in Cash
25,902.90
39,635.50
58,689.50
16,999.00
2,660.50
Free Cash Flow
88,088.10
17,118.00
23,437.80
47,111.50
39,505.20
Net Assets from Acquisitions
-
-
18,169.70
-
-
Other Sources
105,308.60
154,153.40
127,482.20
149,894.80
170,498.60
Change in Capital Stock
130,401.40
3,919.20
4,062.20
110,404.60
8,173.80
Exchange Rate Effect
4.50
0.70
0.10
-
-
Other Uses
173,185.60
241,635.50
31,592.40
256,500.00
108,000.00

About MorphoSys

View Profile
Address
SemmelweisstraƟe 7
Planegg Bayern (Bavaria) 82152
Germany
Employees -
Website http://www.morphosys.de
Updated 07/08/2019
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds.